Prostate cancer radiotherapy more precisely targeted with [PET/CT] nuclear medicine imaging

Current standard imaging techniques for initial staging of prostate cancer often underestimate the extent of disease beyond the prostate. A study featured in The Journal of Nuclear Medicine‘s November issue demonstrates that prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) can pinpoint prostate cancer locations with superior accuracy. {read more here}

By combining a robotic arm-assisted needle navigation system with PET/CT, researchers in India are performing more-accurate targeted biopsies for suspicious bone and bone marrow lesions with near-perfect diagnostic results, according to a study published online November 1 in the American Journal of Roentgenology. {read more here}

By learning to identify the metabolic patterns of Alzheimer’s disease, a deep-learning algorithm for brain FDG-PET studies can accurately predict the onset of this devastating disease years before a clinical diagnosis can be made, according to new research published online in Radiology. {read more here}

Clinical reporting strategies for PET/CT imaging exams in the oncology setting vary widely, according to results of a worldwide survey of clinicians published in the Journal of Nuclear Medicine. Thirty percent of respondents reported they were unaware reporting guidelines existed. {read more here}